InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Protecting life science patents in Latin America


Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Ci­a, Guillermo Carey of HarneckerCarey Carey y Cía and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges

EM: What regulatory changes have most impacted biotechnology and pharmaceutical patents recently? AL: There was an amendment to the Mexican General Health Law in June 2009 which defined biotechnological drugs and allowed for the approval of follow-on biologics, or biocomparables. ...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @devlinhartline: I'll be live-tweeting today's PTAB teleforum here: @cpipgmu

Aug 18 2017 03:53 ·  reply ·  retweet ·  favourite
ManagingIP profile

All in the IP community will be thinking of the victims of the #Barcelona attack, especially given warm welcome rec… https://t.co/HB9SDBERe2

Aug 18 2017 01:29 ·  reply ·  retweet ·  favourite
ManagingIP profile

Consumers mistake lookalikes for brands in 20% cases when both are on shelf - @JN_BrandsGroup @AcuityIntel research… https://t.co/SDxipoYf2O

Aug 18 2017 10:44 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

Mid Year 2017

Eastern District suffers Heartland attack

The Supreme Court’s TC Heartland v Kraft decision has been hailed as the death knell for the Eastern District of Texas, with one analysis predicting a 69% drop in filing there. But, as Natalie Rahhal reports, the picture may be more nuanced than that



Most read articles

Supplements